{"id":"prtimes-125075","slug":"prtimes-125075","canonical_name":"ペリオセラピア株式会社","entity_type":"business","schema_org_type":"Organization","canonical_url":"https://ida.idaeo.ai/prtimes-125075","sameAs":["https://periotherapia.co.jp/"],"public_ids":{"sameAs":["https://periotherapia.co.jp/"],"citation":{"v":1,"faq":[{"a":{"en":"Periotherapia Co., Ltd. is a biotech developing antibody drugs. It raised ¥575 million in Series D2, plus up to ¥1.08 billion from AMED, totaling over ¥1.6 billion. Funds will advance clinical trials for breast cancer drug PT0101 and expand pipeline.","ja":"ペリオセラピア株式会社は、抗体医薬品を開発するバイオベンチャー。シリーズD2で5.75億円を調達し、AMED補助金と合わせ16億円超を確保。乳がん治療薬PT0101の臨床試験を推進する。","ko":"ペリオセラピア株式会社의 IDA 공개 프로필입니다.","zh":"ペリオセラピア株式会社（Periotherapia）是一家開發抗體藥物的生技公司。在D2輪募資中籌得5.75億日圓，加上AMED補助金共超過16億日圓。資金將用於推進乳癌抗體藥PT0101的臨床試驗及擴充產品線。"},"q":{"en":"What is ペリオセラピア株式会社?","ja":"ペリオセラピア株式会社とは？","ko":"ペリオセラピア株式会社은(는) 어떤 곳인가요?","zh":"ペリオセラピア株式会社是什麼？"}}],"kind":"business","title":"ペリオセラピア株式会社｜企業情報・公式リンク","booking":[],"summary":{"en":"Periotherapia Co., Ltd. is a biotech developing antibody drugs. It raised ¥575 million in Series D2, plus up to ¥1.08 billion from AMED, totaling over ¥1.6 billion. Funds will advance clinical trials for breast cancer drug PT0101 and expand pipeline.","ja":"ペリオセラピア株式会社は、抗体医薬品を開発するバイオベンチャー。シリーズD2で5.75億円を調達し、AMED補助金と合わせ16億円超を確保。乳がん治療薬PT0101の臨床試験を推進する。","ko":"ペリオセラピア株式会社의 IDA 공개 프로필입니다.","zh":"ペリオセラピア株式会社（Periotherapia）是一家開發抗體藥物的生技公司。在D2輪募資中籌得5.75億日圓，加上AMED補助金共超過16億日圓。資金將用於推進乳癌抗體藥PT0101的臨床試驗及擴充產品線。"},"modified":"2026-06-14","published":"2026-06-14","info_table":[],"description":"ペリオセラピア株式会社は、抗体医薬品を開発するバイオベンチャー。シリーズD2で5.75億円を調達し、AMED補助金と合わせ16億円超を確保。乳がん治療薬PT0101の臨床試験を推進する。"},"corp_src":"kokuzei_unique","anchor_method":"exa+curl200","houjin_source":"v6-name_norm+2sig","jp_corp_number":"9120901039018","anchor_found_at":"2026-06-19","name_number_gate":"pass","houjin_bango_self":"9120901039018","houjin_match_name":"ペリオセラピア株式会社"},"owner_published":{"available":false,"published_at":null,"source":null},"freshness":{"observed_at":"2026-06-18T17:51:04.600Z","expires_at":null,"is_stale":null,"source":"entity.last_updated"},"provenance":{"source":"tqaeo.public.ida_entities_public.public_ids.owner_published","generated_at":"2026-09-03T12:35:22.166Z","owner_published_source":null,"contract_version":"owner-published-freshness/v1","sameAs_policy":"owner_published_does_not_upgrade_verification_level"},"verification_level":"strong","edge_summary":{"total_edges":1,"sameAs_eligible_edges":1,"strongest_edge_tier":"strong","public_id_count":1},"last_updated":"2026-06-18T17:51:04.600Z"}